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Summary  Urinary  tract  infections  (UTIs),  which  are  among  the  most  prevalent  bacterial  infec-
tions  worldwide,  are  mainly  attributed  to  uropathogenic  Escherichia  coli  (UPEC).  Because  of
frequent  antibiotic  treatment,  antimicrobial  resistance  constitutes  an  increasing  therapeutic
problem.  Antagonists  of  the  mannose-speciﬁc  bacterial  lectin  FimH,  a  key  protein  mediating
the  adhesion  of  UPEC  to  human  bladder  cells,  would  offer  an  alternative  anti-adhesive  treat-
ment  strategy.  In  general,  FimH  antagonists  consist  of  a  mannose  moiety  and  a  wide  range  of
lipophilic  aglycones.  Modiﬁcations  of  the  mannose  core  led  to  a  distinct  drop  in  afﬁnity.  A  visual
inspection  of  the  crystal  structure  of  FimH  revealed  a  previously  unexplored  cavity  surrounded
by  Ile13,  Phe142  and  Asp140,  which  could  be  reached  by  functional  groups  in  the  equatorial
2-position  of  the  mannose.  Here,  we  describe  the  synthesis  of  2-C-branched  mannosides  and
evaluation  of  their  pharmacodynamic  properties.  ITC  experiments  with  the  selected  antagonists
revealed  a  drastic  enthalpy  loss  for  all  2-C-branched  antagonists,  which,  however,  is  partially
compensated  by  an  entropy  gain.  This  supports  the  hypothesis  that  the  target  cavity  is  too  small
to  accommodate  2-C-substituents.
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ract  infections  (UTIs)  are  among  the  most  prevalent
 infections  affecting  millions  of  people  (Foxman
00).  They  are  mainly  associated  with  uropathogenic
ia coli  (UPEC)  (Roland,  2002).  Currently,  the
 treatment  involves  antibiotics  (Hooton  et  al.,
n,  2003)  which  can  induce  resistance,  especially
quently  applied  (Sanchez  et  al.,  2012).  Therefore,
d  efﬁcient  non-antibiotic  approaches  are  urgently
 ﬁrst  step  of  the  infection  cycle,  UPEC  attach  to
l cells  of  the  host  by  means  of  the  bacterial  adhesin
H,  which  is  located  at  the  tip  of  the  approximately
erial  type  1  pili  (Mulvey  et  al.,  2000;  Schilling  et  al.,
is  allows  UPEC  to  evade  elimination  from  the  host
 by  the  bulk  ﬂow  of  the  urine.  FimH  is  composed  of
domain  (FimHLD)  containing  a  carbohydrate  recog-
main  (CRD)  and  a  pilin  domain  (FimHPD)  regulating
h  between  the  high  and  low  afﬁnity  states  of  the
Trong  et  al.,  2010).
than  thirty  years  ago,  Firon  et  al.  (1982,  1983,  1987)
 on  aryl  -D-mannosides  abolishing  FimH-mediated
ion of  UPEC  with  mannan-containing  yeast  cells
omyces cerevisiae)  in  in  vitro  assays.  Over  the
 the  last  few  years,  a  range  of  highly  potent  mono-
ntagonists  consisting  of  a  mannose  moiety  and  a
 aglycone  was  reported  (Bouckaert  et  al.,  2005;
et  al.,  2006;  Han  et  al.,  2010;  Klein  et  al.,  2010;
o et  al.,  2011;  Han  et  al.,  2012;  Pang  et  al.,  2012;
al.,  2012;  Schwardt  et  al.,  2011;  Kleeb  et  al.,  2015;
 et  al.,  2013;  Jarvis  et  al.,  2016;  Chalopin  et  al.,
e  various  aglycones  provide  hydrophobic  contacts
stacking  interactions  to  amino  acids  forming  the
 to  the  mannose  binding  pocket.  This  entrance
yrosine  gate’  is  composed  of  two  tyrosines  and  one
e. However,  the  pharmacokinetic  properties,  e.g.,
 and/or  permeability,  of  most  of  the  reported  FimH
sts are  not  suitable  for  an  oral  application.  For
hemical and  pharmacokinetic  reasons,  the  numer-
rted  multivalent  FimH  antagonists  (Lindhorst  et  al.,
gahori  et  al.,  2002;  Appeldoorn  et  al.,  2005;  Patel
horst,  2006;  Touaibia  et  al.,  2007;  Durka  et  al.,
uckaert  et  al.,  2013)  are  rather  suited  for  the
f  E.  coli  induced  colitis  ulcerosa,  a  form  of  inﬂam-
owel  disease  (Barnich  et  al.,  2007;  Carvalho  et  al.,
 interacting  with  FimH,  the  mannose  moiety  estab-
erfect  hydrogen  bond  network  (Hung  et  al.,  2002).
ery  hydroxyl  group  of  mannose  is  part  of  this
 the  removal/replacement  of  individual  various
 groups  or  the  replacement  of  the  whole  mannose
y  other  hexoses  (e.g.,  glucose,  galactose,  fruc-
ulted  in  a  signiﬁcant  loss  of  afﬁnity  (Bouckaert
005;  Han  et  al.,  2010;  Old,  1972;  Fiege  et  al.,
oreover,  recently  reported  1-C-branched  mannose
es bearing  additional  equatorial  groups  at  the
 carbon  also  showed  reduced  activity  compared  to
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al  inspection  of  the  crystal  structure  of  FimHLD
llized  with  n-heptyl  -D-mannoside  (1,  PDB  ID:
iege  et  al.,  2015)  revealed  a  previously  unexplored
bic cavity  formed  by  Ile13,  Phe142  and  Asp140,
 located  close  to  the  entrance  to  the  mannose-
ocket  (Fig.  1).  By  extending  the  2-position  of  the
 moiety  with  equatorial  substituents  (→  derivatives
g.  2),  an  interaction  with  the  hydrophobic  cavity
ecome  possible.
aption  of  the  synthetic  pathway  of  previously
 2-C-branched  mannose  derivatives,  in  which  the
n is  modiﬁed  at  an  early  stage,  lead  to  rather  labori-
aches  (Mitchell  et  al.,  2007).  We  therefore  planned
onvergent  synthesis  with  a more  ﬂexible  introduc-
glycones  as  well  as  equatorial  substituents  in  the
n.
and discussion
hetic  route  to  2-C-branched  FimH  antagonists  fulﬁls
irements:  The  facile  introduction  of  various  agly-
 well  as  various  equatorial  C-substituents  in  the
ion of  the  mannose  moiety.
is
hesis  of  the  2-C-branched  mannoside  donor  5  is
 in  Scheme  1.  The  2-C-modiﬁed  D-mannofuranose
ynthesized  according  to  a literature  procedure
from  commercially  available  D-mannose  (Witczak
984).  Selective  benzylation  of  the  hydroxymethyl
ing  dibutyltin  oxide  (Malleron  and  David,  1998)  fol-
 cleavage  of  the  acetonides  under  acidic  conditions
the  2-C-branched  D-mannopyranose  4  (Waschke
11).  For  its  perbenzoylation  with  benzoyl  chloride
nce  of  a  catalytic  amount  of  4-dimethylamino-
(DMAP)  in  dry  pyridine,  elevated  temperature
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nityModiﬁcations  of  the  mannose  moiety  of  n-heptyl  -D-mannop
0 ◦C)  had  to  be  applied.  Subsequently,  the  gly-
nor  5  was  obtained  by  reaction  with  thiophenol
3·Et2O  as  a  promoter.  To  couple  donor  5  with  1-
, different  promoters  were  tested.  Whereas  with
OTf or  NIS/TfOH  donor  5  was  only  partially  con-
fter  24  h,  it  reacted  within  minutes  in  the  presence
ercially  available  p-nitrobenzenesulfenyl  chloride
SCl)  accompanied  by  silver  triﬂate  (AgOTf)  (Crich
08).  Apart  from  the  desired  -anomeric  mannoside
the  2-OH  deprotected  -anomer  7  (32%)  and  the  2-
tected  -anomer  8  (5%)  were  obtained  as  well.  As
ﬂate-mediated  glycosylation  has  been  reported  to
artial  transesteriﬁcation  affecting  acetyl  groups  at
position,  low  stereoselectivity  of  the  glycosylation
 was  not  unexpected  (Ziegler  et  al.,  1990;  Nukada
99;  Murakami  et  al.,  2007).
nctionalize  the  equatorial  substituent  in  the  2-C-
 6  was  debenzylated  by  catalytic  hydrogenolysis  to
e  primary  alcohol  9.  However,  attempts  to  mesy-
rimary  hydroxyl  group  failed.  Since  we  attributed
reactivity  of  the  hydroxyl  group  in  9  to  steric  hin-
we  switched  to  mannoside  7  with  an  unprotected
roxyl  group  in  the  2-position.
d,  after  hydrogenolysis  of  7  (→11),  we  were  able
ively  mesylate  the  primary  hydroxyl  groups  (→12).
, displacement  of  the  mesylate  by  ﬂuoride  using  KF
c  solvent  in  presence  of  crown  ether  at  elevated
ture afforded  epoxide  14  instead  of  the  desired  ﬂu-
.  Under  these  reaction  conditions,  the  strongly  basic
is  obviously  deprotonating  the  axial  hydroxyl  group
 by  conversion  of  mesylate  12  into  the  epoxide  14
ramolecular  SN2  mechanism.  With  an  excess  of  LiCl,
14  could  be  opened,  leading  to  the  chloride  15  in
.  By  acting  as  Lewis  acid,  the  large  excess  of  lithium
 facilitate  opening  of  the  epoxide.  Apart  from  the
route,  substituents  can  be  introduced  directly  by
ilic substitution  (see  Scheme  2).  However,  preva-
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(Th:  throoside  (1)  by  equatorial  substituents  in  the  2-position.
ynthesis  of  a series  of  2-C-branched  FimH  antago-
epicted  in  Scheme  2.  Debenzoylation  of  6  under
 conditions  (→2b)  followed  by  Pd(OH)2-catalyzed
olysis afforded  test  compound  2a.  The  conﬁgura-
he  anomeric  carbon  of  deprotected  derivative  2a
9  Hz)  was  unambiguously  conﬁrmed  by  the 13C—1H
constant  of  the  anomeric  nuclei  using  undecoupled
 In  general,  the  coupling  constant  for  the  equato-
eric  proton  amounts  to  ∼170  Hz,  while  a  value  of
is  indicative  for  an  anomeric  proton  in  axial  orien-
ubb,  2003).
mesylation  of  11,  chloride  was  introduced  using  LiCl
 by  deprotection  of  the  intermediate  with  sodium
e to  afford  derivative  2d.  Direct  introduction  of
starting  from  mesylate  was  faster  and  gave  a  higher
n  the  already  discussed  opening  of  epoxide  14.
y  traces  of  epoxide  were  observed  by  TLC  control,
tion  seems  to  be  the  prevailing  mechanism  in  this
r case.  However,  more  basic  nucleophiles  may  lead
nt  results.
an  identical  synthetic  approach,  iodide  2c,  cyanide
zide  2h  were  obtained  with  NaI,  KCN  and  NaN3
ophiles.  Hydrogenation  of  iodide  2c,  cyanide  2e
e  2h  in  presence  of  Pd(OH)2 on  carbon  yielded
hyl  derivative  2f  and  amine  derivatives  2g  and
ctively.  In  addition,  when  2h  was  hydrogenated
equently  acylated  with  acetyl  chloride  or  propionyl
followed  by  deacetylation  under  Zemplén  condi-
ides  2j  and  2k  were  obtained.
aluate  the  -anomeric  derivative  as  well  in
gical  assay,  -mannoside  8  was  debenzoylated
Scheme  3)  followed  by  hydrogenolysis  to  yield  16a
9  Hz).
 and  thermodynamic  proﬁleities  of  the  2-C-branched  mannosides  were  deter-
 a  cell-free  competitive  binding  assay  (Table  1)
 et  al.,  2010).  The  assay  uses  FimHLD-Th-His6
mbin  cleavage  site)  as  a  target  protein  and  a
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Scheme  1  (a)  i.  BnBr,  Bu2SnO,  TBAB,  toluene,  120 ◦C  →  80 ◦C,  24  h;  ii.  Amberlyst-15  (H+),  EtOH,  H2O,  50 ◦C,  43  h,  90%;  (b)  i.
BzCl, DMAP,  pyridine,  120 ◦C,  48  h;  ii.  PhSH,  BF3·Et2O,  DCM,  0 ◦C  →  rt,  24  h,  42%;  (c)  1-heptanol,  p-NO2PhSCl,  AgOTf,  DCM,  4Å  MS,
0 ◦C  →  rt,  5  h,  32%  for  6,  32%  for  7,  5%  for  8;  (d)  Pd(OH)2/C,  H2,  EtOH,  AcOH,  rt,  22  h,  86%;  e)  MsCl,  TEA,  DCM,  0 ◦C  →  65 ◦C,  7  h,
0%; (f)  Pd  6  h,  
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,  90 ◦C,  7  h,  41%.
ted  polyacrylamide  glycopolymer  as  competitor.
ion of  biotin  with  streptavidin-horseradish  per-
allows  quantiﬁcation  of  the  bound  polymer  and
 the  determination  of  the  IC50.  The  activity  of
gonists  was  measured  twice  in  duplicates.  The
st n-heptyl  -D-mannopyranoside  (1)  was  used  as
ce  compound  and  tested  in  parallel  to  ensure  com-
y. The  afﬁnities  are  referred  to  the  activity  of  1  as
ition  to  the  competitive  binding  assay,  ITC  exper-
ere  performed  with  mannosides  1,  2a  and  2f  to
 thermodynamic  ﬁngerprint  of  mannose-modiﬁed
agonists  (Table  2).  ITC  enables  direct  measurement
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hich  are  further  used  to  calculate  the  changes  in
gy  (G◦)  and  entropy  (S◦)  (Chen  and  Wadsö,  1982;
 al.,  1990).
reductio
stituents
Table 1)  86%;  (h)  KF,  Kryptoﬁx  2.2.2,  DMSO,  100 ◦C,  2  h,  85%;  i)
tunately,  all  2-C  modiﬁcations  proved  to  be  detri-
o  the  afﬁnity.  Already  the  smallest  substituent,
l  group  (→2f),  resulted  in  a  2.8-fold  higher  IC50
comparable  4.1-fold  drop  in  activity  was  observed
his  ﬁnding  might  be  explained  by  an  unexpected
able steric  clash  of  Ile13  and/or  Phe142  with  the
roup  already  too  big  to  ﬁt  to  the  targeted  cavity.
othesis  is  supported  by  the  considerably  improved
erm  (−TS◦ −17.2  kJ/mol)  compared  to  the  ref-
,  indicating  an  increased  conformational  ﬂexibility
and.  The  resulting  disruption  of  the  hydrogen  bond
within  the  pocket  is  also  reﬂected  by  a  substan-
ine  of  enthalpy  (H◦ +20.6  kJ/mol).  A  further
n in  afﬁnity  to  the  micromolar  level  for  larger  sub-
, e.g.,  iodomethyl  and  chloromethyl  (→2c  and  2d,
is  in  full  agreement  with  this  argumentation.
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Scheme  2  (a)  MeONa/MeOH,  rt,  4  h,  85%;  (b)  Pd(OH)2/C,  H2,  EtOH,  rt,  6  h,  75%;  (c)  i.  MsCl,  TEA,  DCM,  0 ◦C  →  rt,  1.5—6  h;  ii.  NaI,
LiCl, KCN  or  NaN3,  DMF  or  DMSO,  70—100 ◦C,  3—64  h;  iii.  MeONa/MeOH,  rt,  1—6  h,  39%  for  2c,  38%  for  2d,  11%  for  2e,  73%  for  2h;
(d) Pd(OH)2/C,  H2,  EtOH,  TEA,  rt,  44  h,  91%;  (e)  i.  Pd(OH)2/C,  H2,  MeOH  or  EtOH,  rt,  3—11  h;  ii.  0.1%  TFA  or  0.01  M  HCl,  H2O,  MeOH,
76% for  2 CH2C
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ectedly,  the  benzyloxymethyl  group  in  2b,  despite
ess,  only  slightly  reduced  the  activity  compared  to
yl  substituent  (→2f).  Furthermore,  2b  performed
mpared  to  the  halogens  2c  and  2d.  This  may  result
maller  van  der  Waals  radius  of  oxygen  compared
de  or  iodide.  Moreover,  a  solvent  exposed  phenyl
be  involved  in  non-speciﬁc  hydrophobic  interactions
 surface  of  the  protein,  attenuating  the  negative
 the  size  of  the  2-C-branch.
ntagonists  bearing  hydrogen  bond  donating  groups,
a  hydroxyl  group  (→2a),  an  amine  (→2i)  or  an
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 Compared  to  the  methyl  group  (→2f),  this  sub-
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Scheme  3  (a)  MeONa/MeOH,  rt,  2  h,  68%;  (b)  Pd(OH)2/C,  H2,  EtOH,  rt,  3  h,  93%.
Table  1  Afﬁnity  of  FimH  antagonists.  The  rIC50 values  were  calculated  by  dividing  the  IC50 of  the  compound  of  interest  by  the
IC50 of  the  reference  compound  n-heptyl  -D-mannopyranoside  (1).  rIC50 values  below  1.0  are  obtained  for  antagonists  more
active  than  reference  compound  1,  whereas  rIC50 above  1.0  are  obtained  for  antagonists  less  active  than  reference  compound
1.
Entry  Compound  R  IC50 [nM]  rIC50
1  1
O
OH
OH
HO
HO
O
48.9—65.2  1
O
OH
OH
HO
HO
OR
2  2a  OH  311.0  4.9
3 2b O 340.9  5.4
4 2c  l  >2000  38.9
5  2d  Cl  >2000  304
6  2e  CN  522.3  9.7
7 2f  H  181.2  2.8
8 2g  CH2NH2·HCl  >2000  37.1
9  2h  N3 437.0  6.9
10 2i  NH2·CF3COOH  135.0  2.1
11 2j
H
N CH3
O
182.5  3.4
12 2k
H
N CH2CH 3
O
295.2  5.5
O
OH
OH
HO
HO
R
O
13  16a  OH  446.4  7.0
14 16b O 4400  69.4
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Table  2  Thermodynamic  proﬁle  of  FimH  antagonists  in  binding  to  FimHLD-Th-His6 at  25 ◦C  and  pH  7.4.
Entry  Compound  R  KD [nM]  G◦ [kJ/mol]  H◦ [kJ/mol]  −TS◦ [kJ/mol]
 
O
OH
OH
HO
HO
O
1  1  28.9  −43.0  −50.3  7.3
O
OH
OH
HO
HO
OR
2  2f  H  118.6  −39.5  −29.7  −9.9
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